Ronald Andrews

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Insight Genetics, Inc. engages in the diagnosis, monitoring, and treatment of cancer. It specialize in the discovery, development, and commercialization of companion diagnostics. The company was founded in 2007 and is headquartered in Nashville, TN.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.